GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Scaled Net Operating Assets

Intravenous Infusions (XGHA:IIL) Scaled Net Operating Assets : (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Intravenous Infusions's operating assets for the quarter that ended in . 20 was GHS Mil. Intravenous Infusions's operating liabilities for the quarter that ended in . 20 was GHS Mil. Intravenous Infusions's Total Assets for the quarter that ended in . 20 was GHS Mil. Therefore, Intravenous Infusions's scaled net operating assets (SNOA) for the quarter that ended in . 20 was .


Intravenous Infusions Scaled Net Operating Assets Historical Data

The historical data trend for Intravenous Infusions's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Scaled Net Operating Assets Chart

Intravenous Infusions Annual Data
Trend
Scaled Net Operating Assets

Intravenous Infusions Semi-Annual Data
Scaled Net Operating Assets

Competitive Comparison of Intravenous Infusions's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intravenous Infusions's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Scaled Net Operating Assets falls into.



Intravenous Infusions Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Intravenous Infusions's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(A: . 20 )
=(Operating Assets (A: . 20 )-Operating Liabilities (A: . 20 ))/Total Assets (A: . 20 )
=(-)/
=

where

Operating Assets(A: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

Intravenous Infusions's Scaled Net Operating Assets (SNOA) for the quarter that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(Q: . 20 )
=(Operating Assets (Q: . 20 )-Operating Liabilities (Q: . 20 ))/Total Assets (Q: . 20 )
=(-)/
=

where

Operating Assets(Q: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intravenous Infusions Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.